Physician profile
Joseph Alia
NPI 1265424584
$8,284.51
in general payments reported to CMS, 2019-2025
57 companies · $1,033 in 2025
The $1,033 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,248 · 2020: $834 · 2021: $1,310 · 2022: $1,487 · 2023: $1,269 · 2024: $1,103 · 2025: $1,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,388 · Entertainment: $17.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,388.10 |
| Entertainment | $17.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $773.68 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $724.98 | 2019-2025 | Repatha, Otezla, Repatha |
| Abbvie INC. | $668.09 | 2021-2025 | Vraylar, Ubrelvy, Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $616.00 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $533.82 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $479.84 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $430.31 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $406.20 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $284.17 | 2019-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $240.38 | 2020-2023 | Verquvo, Belsomra, Januvia |
| Abbott Laboratories | $232.19 | 2020-2025 | Proclaim, Merlin@Home, Jot Dx |
| Bayer Healthcare Pharmaceuticals INC. | $227.11 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $198.58 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $168.09 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $161.06 | 2019-2025 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $153.41 | 2020-2022 | |
| Esperion Therapeutics, INC. | $131.42 | 2021-2025 | Nexletol |
| Genzyme Corporation | $121.83 | 2025 | |
| Boston Scientific Corporation | $118.39 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $114.71 | 2019-2021 | |
| Allergan, INC. | $104.50 | 2019-2020 | |
| Ardelyx, INC. | $102.51 | 2024-2025 | Ibsrela |
| Nevro Corp. | $85.19 | 2021-2023 | Senza |
| Exact Sciences Corporation | $82.46 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $82.03 | 2024-2025 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $78.42 | 2020-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biohaven Pharmaceuticals, INC. | $71.71 | 2021 | |
| Astellas Pharma US INC | $70.47 | 2024-2025 | Veozah |
| Teva Pharmaceuticals USA, INC. | $60.76 | 2019 | |
| Lucid Diagnostics INC. | $58.10 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $48.92 | 2022 | |
| Xeris Pharmaceuticals, INC. | $48.18 | 2023 | Gvoke Hypopen |
| Ironwood Pharmaceuticals, INC | $38.49 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $36.22 | 2022-2023 | Amvuttra |
| Idorsia Pharmaceuticals US INC | $34.52 | 2023 | Quviviq |
| Seqirus USA INC | $32.52 | 2024-2025 | Fluad, Flucelvax |
| Mayne Pharma Commercial LLC | $31.86 | 2023 | |
| Angiodynamics, INC. | $30.97 | 2025 | Auryon Laser System 100-120 Vac |
| Ethicon US, LLC | $30.69 | 2020 | |
| Ethicon INC. | $30.52 | 2024 | Monarch Platform |
| Novartis Pharmaceuticals Corporation | $28.86 | 2019-2022 | |
| Teleflex LLC | $23.87 | 2022 | |
| Hologic Sales and Service, LLC | $23.62 | 2023 | Aptima |
| Eisai INC. | $22.85 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.26 | 2025 | Caplyta |
| Alexion Pharmaceuticals, INC. | $22.23 | 2022 | |
| Agios Pharmaceuticals, INC. | $20.38 | 2024 | Pyrukynd |
| Takeda Pharmaceuticals U.S.A., INC. | $20.15 | 2019 | |
| Phathom Pharmaceuticals, INC. | $20.13 | 2024 | Voquezna |
| Renalytix Ai, INC. | $19.53 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Inspire Medical Systems, INC. | $19.02 | 2024 | Inspire |
| Kowa Pharmaceuticals America, INC. | $17.79 | 2022 | |
| Daiichi Sankyo INC. | $17.62 | 2020 | |
| Optos, INC. | $17.23 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Medtronic Vascular, INC. | $16.11 | 2020 | |
| Shield Therapeutics INC | $15.55 | 2022 | |
| Amarin Pharma, INC. | $14.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Alia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.